SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
-4.9%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$2.47B
AUM Growth
+$2.47B
(-8.5%)
Cap. Flow
-$25.5M
Cap. Flow
% of AUM
-1.03%
Top 10 Holdings %
Top 10 Hldgs %
45.51%
Holding
112
New
16
Increased
28
Reduced
14
Closed
11
Top Buys
| 1 |
Home Depot
HD
|
$35.8M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$31.6M |
| 3 |
Bank of America
BAC
|
$31.5M |
| 4 |
89bio
ETNB
|
$30M |
| 5 |
Chipotle Mexican Grill
CMG
|
$27.1M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$97.4M |
| 2 |
Coca-Cola
KO
|
$51.7M |
| 3 |
Starbucks
SBUX
|
$47M |
| 4 |
CRH
CRH
|
$37.2M |
| 5 |
McDonald's
MCD
|
$30M |
Sector Composition
| 1 | Healthcare | 65.45% |
| 2 | Technology | 11.42% |
| 3 | Consumer Discretionary | 7.21% |
| 4 | Financials | 5.81% |
| 5 | Communication Services | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Arcutis Biotherapeutics
ARQT
$1.86B
| $179M | 6.63% | 11,422,978 +23,840 | +0.2% | +$373K |
|
2
Biohaven
BHVN
$1.63B
| $135M | 5.01% | 5,620,271 | – | – |
|
3
Benitec Biopharma
BNTC
$348M
| $128M | 4.77% | 9,876,506 +916,497 | +10% | +$11.9M |
|
4
Legend Biotech
LEGN
$6.41B
| $127M | 4.72% | 3,749,965 +253,731 | +7% | +$8.61M |
|
5
Insmed
INSM
$28.8B
| $114M | 4.22% | 1,492,383 -119,178 | -7% | -$9.09M |
|
|
6
89bio
ETNB
$1.34B
| $104M | 3.87% | 14,335,244 +4,132,548 | +41% | +$30M |
|
7
Meta Platforms (Facebook)
META
$1.86T
| $104M | 3.84% | 179,664 +9,326 | +5% | +$5.38M |
|
|
ITCI
8
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $92.5M | 3.43% | 700,904 -738,122 | -51% | -$97.4M |
|
|
9
Ultragenyx Pharmaceutical
RARE
$2.89B
| $73.3M | 2.72% | 2,024,500 +873,186 | +76% | +$31.6M |
|
10
Microsoft
MSFT
$3.77T
| $67.6M | 2.51% | 180,125 +61,728 | +52% | +$23.2M |
|
11
Amazon
AMZN
$2.44T
| $67.4M | 2.5% | 354,356 +3,075 | +0.9% | +$585K |
|
12
TSMC
TSM
$1.2T
| $58.2M | 2.16% | 350,514 +4,602 | +1% | +$764K |
|
13
KalVista Pharmaceuticals
KALV
$678M
| $56.7M | 2.1% | 4,913,012 | – | – |
|
14
Apollo Global Management
APO
$77.9B
| $54.3M | 2.02% | 396,540 -67,600 | -15% | -$9.26M |
|
15
Kura Oncology
KURA
$686M
| $49.1M | 1.82% | 7,439,259 +2,362,811 | +47% | +$15.6M |
|
16
Capital One
COF
$145B
| $44M | 1.63% | 245,222 -6,420 | -3% | -$1.15M |
|
17
ArriVent BioPharma
AVBP
$776M
| $43.2M | 1.6% | 2,337,496 +91,496 | +4% | +$1.69M |
|
18
Advanced Micro Devices
AMD
$264B
| $41.5M | 1.54% | 404,008 +66,593 | +20% | +$6.84M |
|
19
Immatics
IMTX
$619M
| $41.2M | 1.53% | 9,135,029 +4,069,752 | +80% | +$18.4M |
|
20
GE Aerospace
GE
$292B
| $40.2M | 1.49% | 200,662 | – | – |
|
21
NVIDIA
NVDA
$4.24T
| $38.2M | 1.42% | 352,765 +172,009 | +95% | +$18.6M |
|
22
EyePoint Pharmaceuticals
EYPT
$797M
| $36.9M | 1.37% | 6,804,091 +21,000 | +0.3% | +$114K |
|
23
Apellis Pharmaceuticals
APLS
$3.48B
| $36M | 1.34% | 1,646,615 +853,428 | +108% | +$18.7M |
|
|
24
Home Depot
HD
$405B
| $35.8M | 1.33% | +97,571 | New | +$35.8M |
|
25
Oracle
ORCL
$635B
| $31.6M | 1.17% | 226,318 | – | – |
|